[Leishmaniasis treatment]

Arch Pediatr. 2010 Jun;17(6):838-9. doi: 10.1016/S0929-693X(10)70137-8.
[Article in French]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Antiprotozoal Agents / adverse effects
  • Antiprotozoal Agents / therapeutic use*
  • Child
  • Developing Countries
  • France
  • Humans
  • Leishmaniasis, Cutaneous / diagnosis
  • Leishmaniasis, Cutaneous / drug therapy*
  • Leishmaniasis, Mucocutaneous / diagnosis
  • Leishmaniasis, Mucocutaneous / drug therapy*
  • Leishmaniasis, Visceral / diagnosis
  • Leishmaniasis, Visceral / drug therapy*

Substances

  • Antiprotozoal Agents